Comparison of Two Culture Methods for Detection of Tobramycin-Resistant Gram-Negative Organisms in the Sputum of Patients with Cystic Fibrosis
Open Access
- 1 January 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (1), 26-30
- https://doi.org/10.1128/jcm.40.1.26-30.2002
Abstract
A culture method utilizing quantitative plating on antibiotic-containing media has been proposed as a technique for the detection of tobramycin-resistant organisms that is more sensitive than standard methods. Typical sputum culture methods quantitate the relative amounts of each distinct morphotype, followed by antibiotic susceptibility testing of a single colony of each morphotype. Sputum specimens from 240 cystic fibrosis patients were homogenized, serially diluted, and processed in parallel by the standard method (MacConkey agar and OF basal medium with agar, polymyxin, bacitracin, and lactose) and by plating on antibiotic-containing media (MacConkey agar with tobramycin added at 25 μg/ml [MAC-25] and 100 μg/ml [MAC-100]). MICs of tobramycin were determined for all Pseudomonas aeruginosa isolates by broth microdilution. Growth of P. aeruginosa on MAC-25 was considered to be equivalent to a tobramycin MIC of ≥16 μg/ml, and growth on MAC-100 was considered to be equivalent to a tobramycin MIC of ≥128 μg/ml. Analysis of method-specific detection rates showed that tobramycin-containing medium was more sensitive than the standard method for the detection of tobramycin-resistant P. aeruginosa, Stenotrophomonas maltophilia , and Achromobacter xylosoxidans but was less sensitive for the detection of Burkholderia cepacia than the standard method. When MICs for P. aeruginosa that grew on tobramycin-containing medium were tested by broth microdilution, the MICs for 28 of 121 strains (23%) growing on MAC-25 and 22 of 56 strains (39%) growing on MAC-100 were MICs <16 and <128 μg/ml, respectively. Addition of a tobramycin-containing MacConkey plate to the routine media for sputum culture may provide additional, clinically relevant microbiologic data.Keywords
This publication has 17 references indexed in Scilit:
- Aminoglycoside‐Resistance Mechanisms for Cystic FibrosisPseudomonas aeruginosaIsolates Are Unchanged by Long‐Term, Intermittent, Inhaled Tobramycin TreatmentThe Journal of Infectious Diseases, 2000
- Effect of Chronic Intermittent Administration of Inhaled Tobramycin on Respiratory Microbial Flora in Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1999
- Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 1999
- Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosisJournal of Antimicrobial Chemotherapy, 1996
- MucoidPseudomonas aeruginosaand cystic fibrosis: The role of mutations inmuclociFEMS Microbiology Letters, 1992
- Genetic transformation of various species ofEnterococcusby electroporationFEMS Microbiology Letters, 1991
- The effect of sublethal concentrations of aminogycosides on adherence of Pseudomonas aeruginosa to hamster tracheal epitheliumJournal of Antimicrobial Chemotherapy, 1987
- Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing mediaDiagnostic Microbiology and Infectious Disease, 1986
- Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-PlaceboThe Journal of Infectious Diseases, 1983
- Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1979